4//SEC Filing
Levine James E. 4
Accession 0000950170-25-038708
CIK 0001213037other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:05 PM ET
Size
5.5 KB
Accession
0000950170-25-038708
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Stock Options
2025-03-11+332,621→ 1,295,117 totalExercise: $3.58Exp: 2035-03-11→ Common Stock (332,621 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on March 11, 2026 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:05 PM ET
- Size
- 5.5 KB